{"paper_id":"c3a08d00-1e6e-4072-9311-8b7233518789","body_text":"Abstract\nUterine artery embolization (UAE) is a minimally invasive technique used to treat uterine fibroids, adenomyosis, and arteriovenous malformations. Fibroids are tumors that arise from the uterine smooth muscle and can cause significant pressure and bleeding symptoms for women. UAE is also a lifesaving procedure for postpartum hemorrhage or high-risk patients with placental abnormalities.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nBozini N, Baracat EC. The history of myomectomy at the Medical School of University of Sao Paulo. Clinics (Sao Paulo). 2007;62(3):209–10.\nAleksandrovych V, Bereza T, Sajewicz M, Walocha JA, Gil K. Uterine fibroid: common features of widespread tumor (review article). Folia Med Cracov. 2015;55(1):61–75.\nLevy G, Hill MJ, Beall S, Zarek SM, Segars JH, Catherino WH. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet. 2012;29(8):703–12.\nStewart EA. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646–55.\nMarshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998;70(3):432–9.\nBaird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology. 2003;14(2):247–50.\nMedikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181–91.\nMcElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974;3(0):425–41.\nFerenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998;4(4):312–22.\nSharma K, Bora MK, Venkatesh BP, Barman P, Roy SK, Jayagurunathan U, et al. Role of 3D ultrasound and Doppler in differentiating clinically suspected cases of leiomyoma and adenomyosis of uterus. J Clin Diagn Res. 2015;9(4):QC08–12.\nACOG Practice Bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112(2 Pt 1):387–400.\nLaughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol. 2011;204(6):496 e1–6.\nViswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep). 2007;154:1–122.\nCarlson KJ, Miller BA, Fowler FJ Jr. The Maine Women’s health study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994;83(4):566–72.\nFriedman AJ, Daly M, Juneau-Norcross M, Rein MS. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril. 1992;58(2):413–5.\nLetterie GS, Coddington CC, Winkel CA, Shawker TH, Loriaux DL, Collins RL. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. Fertil Steril. 1989;51(6):951–6.\nAmirikia H, Evans TN. Ten-year review of hysterectomies: trends, indications, and risks. Am J Obstet Gynecol. 1979;134(4):431–7.\nGambone JC, Reiter RC, Lench JB, Moore JG. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol. 1990;163(2):545–50.\nKeshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy aurveillance – United States, 1994–1999. MMWR. 2002;51(SS05):1–8.\nWallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406.\nJacoby VL, Jacoby A, Learman LA, Schembri M, Gregorich SE, Jackson R, et al. Use of medical, surgical and complementary treatments among women with fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:220–5.\nGupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;(12):CD005073.\nPundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20(3):335–45.\nTakeda A, Manabe S, Hosono S, Nakamura H. Preoperative evaluation of submucosal myoma by virtual hysteroscopy. J Am Assoc Gynecol Laparosc. 2004;11(3):404–9.\nSomigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13(5):465–76.\nFadare O, Wang SA, Renshaw IL. Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases. Diagn Pathol. 2008;3:28.\nACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol. 2007;109(5):1233–48.\nRavina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–2.\nWorthington-Kirsch RL. Uterine artery embolization: state of the art. Semin Interv Radiol. 2004;21(1):37–42.\nGoodwin SC, Spies JB, Worthington-Kirsch R, Peterson E, Pron G, Li S, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol. 2008;111(1):22–33.\nMcLucas B, Voorhees WD, Elliott S. Fertility after uterine artery embolization: a review. Minim Invasive Ther Allied Technol. 2016;25(1):1–7.\nSiskin GP, Eaton LA Jr, Stainken BF, Dowling K, Herr A, Schwartz J. Pathologic findings in a uterine leiomyoma after bilateral uterine artery embolization. J Vasc Interv Radiol. 1999;10(7):891–4.\nAbbara S, Spies JB, Scialli AR, Jha RC, Lage JM, Nikolic B. Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 1999;10(4):409–11.\nSiskin GP, Tublin ME, Stainken BF, Dowling K, Dolen EG. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR Am J Roentgenol. 2001;177(2):297–302.\nKim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007;188(1):176–81.\nBibi S, Ghaffar S, Memon S, Memon S. Severe acute maternal morbidity (SAMM) in postpartum period requiring tertiary hospital care. Iran J Reprod Med. 2012;10(2):87–92.\nKim TH, Lee HH, Kim JM, Ryu AL, Chung SH, Seok Lee W. Uterine artery embolization for primary postpartum hemorrhage. Iran J Reprod Med. 2013;11(6):511–8.\nBrown BJ, Heaston DK, Poulson AM, Gabert HA, Mineau DE, Miller FJ Jr. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol. 1979;54(3):361–5.\nMerland JJ, Houdart E, Herbreteau D, Trystram D, Ledref O, Aymard A, et al. Place of emergency arterial embolisation in obstetric haemorrhage about 16 personal cases. Eur J Obstet Gynecol Reprod Biol. 1996;65(1):141–3.\nLédée N, Ville Y, Musset D, Mercier F, Frydman R, Fernandez H. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol. 2001;94(2):189–96.\nFleming H, Ostör AG, Pickel H, Fortune DW. Arteriovenous malformations of the uterus. Obstet Gynecol. 1989;73(2):209–14.\nKim T, Shin JH, Kim J, Yoon HK, Ko GY, Gwon DI, et al. Management of bleeding uterine arteriovenous malformation with bilateral uterine artery embolization. Yonsei Med J. 2014;55(2):367–73.\nForssman L, Lundberg J, Scherstén T. Conservative treatment of uterine arteriovenous fistula. Acta Obstet Gynecol Scand. 1982;61(1):85–7.\nAuthor information\nAuthors and Affiliations\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2018 Springer International Publishing AG, part of Springer Nature\nAbout this chapter\nCite this chapter\nKeefe, N.A., Haskal, Z.J. (2018). Uterine Artery Embolization. In: Keefe, N., Haskal, Z., Park, A., Angle, J. (eds) IR Playbook. Springer, Cham. https://doi.org/10.1007/978-3-319-71300-7_28\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-71300-7_28\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-71299-4\nOnline ISBN: 978-3-319-71300-7\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}